|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.64 CNY | +2.01% |
|
-0.21% | -38.99% |
| 05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
| 04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chengdu Olymvax Biopharmaceuticals Inc.(XSSC:688319) added to S&P Global BMI Index
| 1st Jan change | Capi. | |
|---|---|---|
| -38.99% | 539M | |
| +2.97% | 94.74B | |
| -4.08% | 37.28B | |
| -13.26% | 32.68B | |
| +73.38% | 27.72B | |
| -11.58% | 16.19B | |
| -1.66% | 13.88B | |
| -11.67% | 11.58B | |
| +190.36% | 10.92B | |
| -52.61% | 9.54B |
CHENGDU OLYMVAX BIOPHARMACEUTICALS INC. 
